Nutra Pharma (NPHC) versus Cronos Group (CRON) Head-To-Head Comparison

Cronos Group ( NASDAQ:CRON ) and Nutra Pharma ( OTCMKTS:NPHC ) are both finance companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, institutional ownership, risk, earnings, profitability, analyst recommendations and valuation.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Cronos Group and Nutra Pharma, as provided by MarketBeat.com. Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cronos Group 0 1 3 0 2.75 Nutra Pharma 0 0 0 0 N/A Cronos Group currently has a consensus target price of $9.00, indicating a potential downside of 38.86%. Given Cronos Group’s higher possible upside, analysts clearly believe Cronos Group is more favorable than Nutra Pharma.

Profitability

This table compares Cronos Group and Nutra Pharma’s net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets Cronos Group -45.72% -3.22% -3.02% Nutra Pharma -4,741.67% N/A -1,740.23% Valuation and Earnings

This table compares Cronos Group and Nutra Pharma’s top-line revenue, earnings per share (EPS) and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cronos Group $3.15 million 827.97 $1.92 million $0.01 1,472.00 Nutra Pharma $120,000.00 6.67 -$4.02 million N/A N/A Cronos Group has higher revenue and earnings than Nutra Pharma.

Insider & Institutional Ownership

12.4% of Cronos Group shares are owned by institutional investors. Comparatively, 0.0% of Nutra Pharma shares are owned by institutional investors. 61.5% of Nutra Pharma shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Cronos Group beats Nutra Pharma on 8 of the 10 factors compared between the two stocks.

Cronos Group Company Profile

Cronos Group Inc., formerly known as PharmaCan Capital Corp., is a principal investment firm. The firm seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada’s Marihuana for Medical Purposes Regulations MMPR. The firm typically invests in companies based in Canada. The firm is primarily an equity investor, may also advance debt as appropriate. It seeks to make minority investments with appropriate governance and shareholder rights. The firm seeks board representation consistent with the size of the investment, but does not need control. Cronos Group Inc. was incorporated in January, 2013 and is based in Toronto, Canada with an additional office in Toronto, Canada.

Nutra Pharma Company Profile Nutra Pharma logo Nutra Pharma Corp., a biopharmaceutical company, acquires, licenses, and commercializes pharmaceutical products and technologies, and homeopathic and ethical drugs for the management of pain, neurological disorders, cancer, and autoimmune and infectious diseases primarily in the United States. The company offers Nyloxin and Nyloxin Extra Strength products, which are used as an oral spray for treating back pain, neck pain, headaches, joint pain, migraines, and neuralgia, as well as a topical gel for treating joint pain, neck pain, arthritis pain, and pain associated with repetitive stress; Pet Pain-Away, an over-the-counter pain reliever to treat pain in cats and dogs; Luxury Feet, an over-the-counter pain reliever to treat foot pain from high heels and stilettos; Nyloxin Military Strength for treating pain to the United States Military and Veteran’s Administration; and Equine Nyloxin, a topical therapy for chronic pain in horses. It is also developing RPI-78M to treat neurological diseases and autoimmune diseases, including multiple sclerosis, adrenomyeloneuropathy, amyotrophic lateral sclerosis, rheumatoid arthritis, and myasthenia gravis; RPI-MN to treat viral diseases, including human immunodeficiency virus/AIDS and herpes; RPI-78 for pain and arthritis; and RPI-70 for pain. The company has a collaboration agreement with the International Security Group to develop nerve agent counter measures. Nutra Pharma Corp. was founded in 2000 and is based in Coral Springs, Florida.

Receive News & Ratings for Cronos Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Cronos Group and related companies with MarketBeat.com’s FREE daily email newsletter .

Click Here to Continue...


Add a Comment

Your email address will not be published. Required fields are marked *